Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Player Avatar NHWeston102 (74.75) Submitted: 7/6/2012 10:13:26 PM : Outperform Start Price: $1.93 KERX Score: +293.85

Outclassed in all its categories but a fair buy-out candidates.

Featured Broker Partners


Advertisement